An Overview of new advancement on Nanoparticles

Authors

Riteek P. Raghuwanshi, Prajwal P. Raghuwanshi, Vinayak A. Katekar, Dr. Swati P. Deshmukh

Abstract

Pharmacogenomics, a pivotal component of personalized medicine, explores the intricate interplay between an individual’s genetic makeup and their response to pharmaceutical interventions. This abstract encapsulates the multifaceted achievements in pharmacogenomics and its transformative influence on the landscape of personalized medicine. Genetic variations, such as single nucleotide polymorphisms and copy number variations, have been unveiled as critical determinants influencing drug metabolism and treatment outcomes. Breakthroughs in deciphering enzyme pathways, particularly those involving cytochrome P450, have shed light on the molecular underpinnings of drug efficacy and safety. The translation of these genetic Insights into tailored treatment plans represents a cornerstone achievement. Case studies highlight instances where pharmacogenomic data guides clinicians in medication selection and dosage adjustments, leading to improved patient outcomes and minimized adverse reactions. The integration of pharmacogenomic testing into routine clinical practice marks a significant stride, although challenges in interpretation and ethical considerations persist.
Anticipating the future, this abstract envisions advancements in technology, data analysis, and broader implementation across medical specialties. The global impact of pharmacogenomics on healthcare disparities and accessibility is explored, emphasizing the need for equitable distribution of personalized medicine benefits. Despite challenges, pharmacogenomics stands poised to revolutionize patient-centered care, offering a glimpse into a future where treatments are meticulously tailored to individual genetic profiles, ushering in an era of precision and efficacy in medicine.

Keywords

Pharmacogenomics, Personalized medicine, Genetic variations, Ethical considerations, Future prospects, Global impact, Healthcare disparities, Accessibility 16. Precision medicine, Pharmaceutical interventions, Molecular underpinnings, Cytochrome P450, Treatment outcomes, Adverse reactions, Clinical practice, Technology advancements, Data analysis, Medical specialties, Equitable distribution, Patient-centered care, Molecular pharmacology, Therapeutic intervention, Genomic profiling

An Overview of new advancement on Nanoparticles. Riteek P. Raghuwanshi, Prajwal P. Raghuwanshi, Vinayak A. Katekar, Dr. Swati P. Deshmukh. 2024. IJIRCT, Volume 10, Issue 1. Pages 1-11. https://www.ijirct.org/viewPaper.php?paperId=2401037